Reaction
Cytomegalovirus Enteritis reporting signals
As of the last recalculation, Cytomegalovirus Enteritis appears in 347 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 254.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 45 | 254.1 | 255.1 |
| Valganciclovir | 55 | 207.8 | 208.4 |
| Valganciclovir Hydrochloride | 55 | 207.8 | 208.4 |
| Ganciclovir Sodium | 27 | 165.9 | 166.3 |
| Ganciclovir | 26 | 164.6 | 165.1 |
| Anti-Thymocyte Globulin (Rabbit) | 13 | 100.4 | 100.5 |
| Tacrolimus Ointment 0.1% | 111 | 78.1 | 78.2 |
| Tacrolimus Extended-Release Capsules | 111 | 77.9 | 78.0 |
| Tacrolimus | 124 | 73.3 | 73.4 |
| Thiotepa | 8 | 51.4 | 51.5 |
| Sirolimus | 8 | 36.4 | 36.5 |
| Bendamustine Hcl | 9 | 35.7 | 35.7 |
| Busulfan | 9 | 35.2 | 35.2 |
| Fludarabine Phosphate | 21 | 34.0 | 34.1 |
| Polatuzumab Vedotin | 5 | 31.2 | 31.2 |
| Obinutuzumab | 5 | 18.5 | 18.5 |